The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ARROWHEAD PHARMACEUTICALS IN COM 04280A100   1,751,726 67,400 SH   SOLE   67,400 0 0
BRIDGEBIO PHARMA INC COM 10806X102   3,069,996 121,200 SH   SOLE   121,200 0 0
CURIS INC COM 231269309   2,911,462 421,951 SH   SOLE   421,951 0 0
FRACTYL HEALTH INC COM 35168W103   7,925,620 1,856,117 SH   SOLE   1,856,117 0 0
INVIVYD INC COM 00534A102   10,173,075 9,248,250 SH   SOLE   9,248,250 0 0
PROQR THRAPEUTICS N V SHS EURO N71542109   1,692,367 1,019,498 SH   SOLE   1,019,498 0 0
ROCKET PHARMACEUTICALS INC COM 77313F106   8,303,690 385,680 SH   SOLE   385,680 0 0
SILENCE THERAPEUTICS PLC ADS 82686Q101   3,516,900 185,100 SH   SOLE   185,100 0 0
SPRINGWORKS THERAPEUTICS INC COM 85205L107   4,158,768 110,400 SH   SOLE   110,400 0 0
TG THERAPEUTICS INC COM 88322Q108   2,874,864 161,600 SH   SOLE   161,600 0 0
WAVE LIFE SCIENCES LTD SHS Y95308105   30,761,095 6,164,548 SH   SOLE   6,164,548 0 0